Skip to main content
Log in

Cancer evolution

A medley of resistance in ovarian cancers

  • News & Views
  • Published:

From Nature Genetics

View current issue Submit your manuscript

Multi-omic profiling of lesions at autopsy reveals a plethora of resistance mechanisms present within individual patients with ovarian cancer. This highlights the extreme challenge faced in treating end-stage disease and underscores the need for new methods of early detection and intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Multi-omic characterization of resistance mechanisms.

References

  1. Iacobuzio-Donahue, C. A. et al. Nat. Rev. Cancer 19, 686–697 (2019).

    Article  CAS  PubMed  Google Scholar 

  2. Burdet, N. L. et al. Nat. Genet. https://doi.org/10.1038/s41588-023-01320-2 (2023).

  3. Rose, P. G., Piver, M. S., Tsukada, Y. & Lau, T. S. Cancer 64, 1508–1513 (1989).

    Article  CAS  PubMed  Google Scholar 

  4. Güth, U. et al. Cancer 110, 1272–1280 (2007).

    Article  PubMed  Google Scholar 

  5. Nguyen, L., Martens, J. W. M., Van Hoeck, A. & Cuppen, E. Nat. Commun. 11, 5584 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Geoff Macintyre.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hernando, B., Macintyre, G. A medley of resistance in ovarian cancers. Nat Genet 55, 361–362 (2023). https://doi.org/10.1038/s41588-023-01303-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-023-01303-3

  • Springer Nature America, Inc.

Navigation